Vimarsana
Biggest News Aggregation in the World

Page 38 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY - Vimarsana News

KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that its lead...

MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke - Vimarsana News

MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke

/PRNewswire/ -- MedRhythms today announced that MR-001, the company's evidence-based neurorehabilitation system to improve walking and ambulation in adults...

FDA approves Alzheimer's drug shown to slow cognitive decline in patients in early stages of the disease - Vimarsana News

FDA approves Alzheimer's drug shown to slow cognitive decline in patients in early stages of the disease

The FDA granted approval to Leqembi on Thursday afternoon, a drug that has been shown to slow cognitive decline in early-stage Alzheimer's patients.

Source: abc11.com
Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker - Vimarsana News

Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker

Abbott's breakthrough technology enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers, which are...

Gene therapy for deadly form of muscular dystrophy gets FDA approval for kids - Vimarsana News

Gene therapy for deadly form of muscular dystrophy gets FDA approval for kids

The U.S. Food and Drug Administration has approved the first gene therapy to treat a deadly form of muscular dystrophy.

Source: wxyz.com